Poster Station 9 (Trillium Ballroom) Moderator: Katie Beadon
P.093 - A case of refractory NF155 Paranodal CIDP with near-complete spontaneous recovery P.100 - A randomized, open-label study on the effect of Nipocalimab on vaccine responses in healthy participants P.094 - A phase 1, multicenter, randomized, placebo-controlled, multiple ascending dose study to evaluate the safety and tolerability of AMX0114 in ALS (LUMINA) P.096 - Final pooled analysis of efficacy and safety of rozanolixizumab cycles in patients with generalised myasthenia gravis: MycarinG and open-label extension studies P.098 - Does single fiber EMG (SFEMG) pair number influence the outcome of patients initially referred for possible myasthenia gravis (MG)? P.099 - Post-hoc evaluation of the clinical effects of nipocalimab, a neonatal fragment crystallizable blocker, over time in the Vivacity MG3 study P.072 - Safety and effectiveness of Nipocalimab in adolescent participants in the open label phase 2/3 Vibrance-mg clinical study
.png)
